PHARMAMAR (ZELTIA GROUP)

pharmamar-zeltia-group-logo

PharmaMar is a company focused on oncology and committed to research and development which takes inspiration from the sea to discover molecules with antitumor activity. It is an integrated company that seeks innovative products to provide healthcare professionals with new tools to treat cancer. It was founded in 1986 and is headquartered in Colmenar Viejo, Madrid, Spain.

#SimilarOrganizations #People #Financial #Website #More

PHARMAMAR (ZELTIA GROUP)

Social Links:

Industry:
Biotechnology Health Care Medical Pharmaceutical

Founded:
1970

Address:
Colmenar Viejo, Madrid, Spain

Country:
Spain

Website Url:
http://www.pharmamar.com

Total Employee:
251+

Status:
Active

Contact:
34 91 846 60 00

Email Addresses:
[email protected]

Technology used in webpage:
SPF SSL By Default ASP.NET IIS Apache 2.4 Sectigo SSL Sectigo Domain SSL Ubuntu IIS 8 Sucuri Cloudproxy


Revenue:
13.93 B
Total Assets:
13.35 B
Total Cash:
1.78 B

Top asked questions

Where is PharmaMar (Zeltia Group)'s headquarters / location ? PharmaMar (Zeltia Group) is located in Colmenar Viejo, Madrid, Spain

How much funding has PharmaMar (Zeltia Group) raised to date? PharmaMar (Zeltia Group) has raised 0

What is PharmaMar (Zeltia Group)'s stock symbol? PharmaMar (Zeltia Group)'s stock symbol is PHM

What is PharmaMar (Zeltia Group)'s official website ? PharmaMar (Zeltia Group)'s official website is http://www.pharmamar.com

Who is PharmaMar (Zeltia Group)'s founder? PharmaMar (Zeltia Group)'s founder is José Maria Fernández Sousa-Faro

Similar Organizations

aop-orphan-pharmaceuticals-logo

AOP Orphan Pharmaceuticals

AOP Orphan Pharmaceuticals engages in developing, marketing, and distributing medicines for orphan indications and complex diseases.

merck-logo

Merck

Merck is a biopharmaceutical company that offers medicines and vaccines for various diseases.

salix-pharmaceuticals-logo

Salix Pharmaceuticals

Salix Pharmaceuticals is a specialty pharmaceutical company focused on the prevention and treatment of gastrointestinal disorders.

sla-pharma-logo

SLA Pharma

SLA Pharma is a pharmaceutical company focused on developing medicines for the prevention and treatment of gastrointestinal disorders.


Current Advisors List

josé-maria-fernández-sousa-faro_image

José Maria Fernández Sousa-Faro Chairman of Board @ PharmaMar (Zeltia Group)
Board_member

Current Employees Featured

josé-maria-fernández-sousa-faro_image

José Maria Fernández Sousa-Faro
José Maria Fernández Sousa-Faro Founder and CEO @ PharmaMar (Zeltia Group)
Founder and CEO
1986-01-01

Founder


josé-maria-fernández-sousa-faro_image

José Maria Fernández Sousa-Faro

Stock Details


Company's stock symbol is PHM. Lastest price : 52.58$. Total volume :431.68k Click reload if you want to check the lastest price on market!!!
Exchange NYSE. Currency in USD. Market state REGULAR

PulteGroup, Inc. (PHM)
Last Price
52.58$
Change
-0.04$ (-0.08%)
Volume
431.68k

Previous Close 52.62
Open 52.16
Day Range 52.10-53.02
Bid 52.88 x 1.1k
Ask 52.87 x 800
Volume 431.68k
Average Volume 2.12M
Market Cap 11.98B
Beta 1.28
52 Week Range 35.03-54.71
Trailing P/E 5.37
Foward P/E 7.42
Dividend (Yield %) 1.22%
Ex-Dividend Date 2022-12-13

Financial Details


According to PharmaMar (Zeltia Group)'s financial reports the company's revenue in 2021 were 13.93B an increase( +18.18%) over the years 2020 revenue that were of 11.04B. In 2021 the company's total earnings were 1.95B while total earnings in 2020 were 1.41B(0%).


Loading ...

Official Site Inspections

http://www.pharmamar.com Semrush global rank: 938.11 K Semrush visits lastest month: 38.19 K

  • Host name: cloudproxy10020.sucuri.net
  • IP address: 192.124.249.20
  • Location: United States
  • Latitude: 37.751
  • Longitude: -97.822
  • Timezone: America/Chicago

Loading ...

More informations about "PharmaMar (Zeltia Group)" on Search Engine

About us | PharmaMar

“PharmaMar is a unique company in terms of inspiration, focus, and successes” ‘Nature distributed medicine everywhere.’ Pliny, the elder, 74 A.D. The Atlantic Ocean formed an …See details»

PharmaMar - Wikipedia

Zeltia was founded in 1939 in Vigo as a spin-off of Miguel Servet laboratories. During these initial years, it focused mainly in the production of drugs for the treatment of cardiovascular and Metabolic Diseases and gynaecologic disorders as controlled-release insuline, sulfonamides, Alkaloids and ephedrine. In 1949, together with other Spanish laboratories, it created the company Antibioticos SA, dedicated to packaging penicillin and streptomycin imported in bulk.See details»

About our team | PharmaMar

We are a multi-disciplinary R&D team of biologists, chemists, clinicians, engineers, computer technicians, lab professionals, biostatisticians, supported by so many more, all …See details»

PharmaMar (Zeltia Group) - Crunchbase Company Profile …

PharmaMar is a company focused on oncology and committed to research and development which takes inspiration from the sea to discover …See details»

Investors | PharmaMar

Born in 1986, the company takes its inspiration for discovery of oncology medicines from the sea. PharmaMar is a unique biotech company focused on marine discovery Our …See details»

PharmaMar - PharmaMar hits the boards running | Edison

Sep 30, 2015 PharmaMar is a Madrid-based company with two business divisions: biopharmaceuticals (based in the Madrid region) and consumer chemicals (based in Galicia). The head company, PharmaMar, is …See details»

PharmaMar (Zeltia Group) Company Profile - Talent Ticker

PharmaMar is a company focused on oncology and committed to research and development which takes inspiration from the sea to discover molecules with antitumor …See details»

Pharmamar, Zeltia Group. Sea Health – Letters from Spain

Feb 11, 2016 Pharmamar, Zeltia Group. Sea Health Pharmamar is a Pharma company which was born because of a dream which remembers a similar plot to Verne’s novel …See details»

PharmaMar (Zeltia Group) - Contacts, Employees, Board …

PharmaMar (Zeltia Group) has 1 current employee profile, Founder and CEO José Maria Fernández Sousa-Faro. PharmaMar (Zeltia Group) has 1 board member or advisor, …See details»

Annual Report Zeltia Group 2012 - pharmamar.com

Securities Info (Stock and Bond) Corporate Governance PipelineSee details»

Zeltia - Wikipedia

Pharmaceutical companies established in 1939 1939 establishments in Spain Companies based in the Community of Madrid Pharmaceutical companies of Spain Chemical companies of Spain Companies listed on …See details»

CORPORATE SOCIAL RESPONSIBILITY - PharmaMar

PHARMAMAR, S.A. is a company inspired by the sea to discover molecules with anti-tumour activity. Its commitment to patients and to research has made PharmaMar a …See details»

Zeltia : PharmaMar announces that its partner Janssen has …

Nov 25, 2014 ZELTIA NEWS PharmaMar announces that its partner Janssen has submitted a New Drug Application for YONDELIS® to the U.S. FDA for the... | November …See details»

PharmaMar (Zeltia Group) - Tech Stack, Apps, Patents & Trademarks

PharmaMar (Zeltia Group) is actively using 10 technologies for its website, according to BuiltWith. These include SPF , SSL by Default , and HSTS. Company Tech Stack by G2 …See details»

Zeltia, S.A.: Contact Details and Business Profile

Zeltia, S.A. is a Business Services, Chemicals, and Drug Manufacturing & Research company located in Colmenar Viejo, Community of Madrid with $194.00 Million in …See details»

PHARMAMAR 68 PharmaMar is

CORPORATE SOCIAL RESPONSIBILITY 2009 - Zeltia. EN. English Deutsch Français Español Português Italiano Român Nederlands Latina Dansk Svenska Norsk Magyar …See details»

CORPORATE SOCIAL RESPONSIBILITY 2009 - Zeltia

CORPORATE SOCIAL RESPONSIBILITY 2009 - Zeltia. EN. English Deutsch Français Español Português Italiano Român Nederlands Latina Dansk Svenska Norsk Magyar …See details»

CORPORATE SOCIAL RESPONSIBILITY 2009 - Zeltia

Corporate social responsibility 2009 - zeltia . show more . show less . epaper read . download epaper ...See details»

CORPORATE SOCIAL RESPONSIBILITY 2009 - Zeltia

CORPORATE SOCIAL RESPONSIBILITY 2009 - ZeltiaSee details»